ISO 25539-3:2024

Overview

ISO 25539-3:2024 - "Cardiovascular implants - Endovascular devices - Part 3: Vena cava filters" is the second-edition international standard that defines requirements for the evaluation of vena cava filter systems (filters and delivery systems). The standard covers nomenclature, design attributes, materials, testing and information supplied by the manufacturer, and includes guidance for in vitro test method development (Annex D). It is intended to be used together with ISO 14630 (general requirements for non-active surgical implants).

Key scope points:

• Applies to filters intended to prevent symptomatic pulmonary embolism by capturing clots in the inferior vena cava (IVC).
• Covers permanent filters, retrievable (optional) filters and their retrieval systems, and convertible filters and conversion systems.
• Useful (but not specific) for filters in other venous locations (e.g., superior vena cava, iliac veins).
• Excludes temporary tethered filters, procedures/devices used prior to filter procedure, and most aspects of viable biological tissues.
• Includes coated and absorbable filters in scope but is not comprehensive for coating or absorbable properties.

Key Technical Topics and Requirements

• Design attributes and nomenclature: standardized naming, configuration and size designation for filters and systems.
• Materials: guidance on materials of construction and relevant considerations for coatings and absorbable components.
• Design evaluation and bench testing: sampling, conditioning, reporting, and a range of bench and analytical tests for filter performance and delivery/retrieval systems.
• Preclinical (in vivo) and clinical evaluation: objectives, protocol considerations, data acquisition and reporting.
• Manufacturing, sterilization and packaging: requirements for sterile products, sterilization residuals, container labeling, and instructions for use.
• Post-market experience: monitoring and reporting expectations to support ongoing safety and performance.
• Informative annexes (A–E) provide failure-mode guidance, clinical/device effect descriptions, test method examples and clinical-use issues.

Practical Applications - Who Uses ISO 25539-3

• Medical device manufacturers developing or modifying vena cava filters, delivery or retrieval systems.
• Regulatory authorities and notified bodies assessing conformity, safety and performance for market approval.
• Testing laboratories and contract research organizations (CROs) designing bench, in vivo and clinical evaluation programs.
• Quality, regulatory and clinical teams preparing technical documentation, labeling and post-market surveillance plans.
• Clinicians and hospital procurement teams referencing device claims and instructions for use.

Related Standards

• ISO 14630 - General requirements for non-active surgical implants
• ISO/TS 17137 - Absorbable implants (as noted)
• ISO 25539-4 - Coating properties for endovascular devices
• ISO 12417-1 - Vascular device–drug combination products

ISO 25539-3:2024 is essential for ensuring consistent evaluation and documentation of vena cava filters, helping stakeholders meet regulatory expectations and support safe clinical use.